Skip to content

Efficacy of Acupuncture in Patients With Mild Depressive Disorder

Efficacy of Acupuncture in Patients With Mild Depressive Disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069359
Enrollment
Unknown
Registered
2023-03-14
Start date
2023-03-15
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild depression disorder

Interventions

Experimental group:Acupuncture
Control group:Sham acupuncture

Sponsors

Guangdong Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of depressive episode in ICD-10, DSM-V, and the diagnostic criteria of "depression disease" in ZY/T001.1-94; 2. Age 18 ~ 65 years old, junior high school education or above; 3. The PHQ-9 scale score in the initial screening was > 5 points; 17 Hamilton Depression Scale (HAMD-17) scores >= 8 points and < 17 points were evaluated by interviews with psychopharmacologists. 4. Right-handed; 5. Sign the informed consent and volunteer to participate in this study.

Exclusion criteria

Exclusion criteria: 1. People with suicidal tendencies; 2. Previous diagnoses of mental disorders, schizophrenia, bipolar disorder, substance abuse (such as alcohol dependence) or other mental disorders; 3. Epileptic seizure history or strong positive family history of epilepsy, organic brain disease and serious physical disease; 4. Patients taking antidepressants within 6 weeks (including 6 weeks); 5. Pregnancy, preparation for pregnancy or lactation; 6. Patients with skin lesions or skin diseases, severe diabetes, tumors and major organ insufficiency or serious internal diseases of liver, kidney, cardiovascular, endocrine, respiratory and hematopoietic systems; 7. Patients with other central or peripheral neuropathy; 8. Subjects who cannot obtain stable cerebral blood flow velocity envelope by transcranial Doppler ultrasound or who have not explored and monitored blood vessels.

Design outcomes

Primary

MeasureTime frame
Patient Health Questionnaire-9, PHQ-9;Hamilton Depression Scale-17, HAMD-17;

Secondary

MeasureTime frame
Beck Depression Inventory-13, BDI-13;Pittsburgh sleep quality index, PSQI;Attention to Positive and Negative Information Scale, APNI;Self-rating depression scale, SDS;Hamilton Anxiety Scale;the vividness of viual imagery questionnaire, VVIQ;Cognitive function measurement paradigm;EEG;transcranial Doppler, TCD;functional magnetic resonance imaging, fMRI;

Countries

China

Contacts

Public ContactWenbin Fu

Guangdon Provincial Hospital of Chinese Medicine

fuwenbin@139.com+86 81887233

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026